cannabis investing Cannara Insiders Form Buying Group to Fully Acquire FSD/FV Pharma’s Position in Cannara
cannabis investing FSD Pharma Generates $7.7 Million in Proceeds and 670 Percent Return on Investment through Sale of Interest in Cannara Biotech
cannabis investing Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce
cannabis investing Cannara Biotech Submits Site Evidence Package to Health Canada for its Quebec Facility
cannabis investing Cannara Biotech Announces Non-Brokered Private Placement of 12,000,000 Common Shares
Nuvau Announces Voting Results of Its Annual and Special Meeting of Shareholders and Announces the Appointment of Steven Bowles as Chair of the Board
SAGA Metals Appoints Accomplished Mining Executive Peter Hogendoorn to Board of Advisors and Engages Xander Capital Partners
Blue Lagoon Announces Major Steps Toward Production: Fully Funded, Government Inspections Passed, and Water Treatment Plant Completed
